Delatestryl (testosterone enanthate) has been shown to increase the risk of blood clots in the leg, a medical condition referred to as deep vein thrombosis (DVT). If DVTs break free and migrate to the lungs, they may result in a life-threatening pulmonary embolism. Signs and symptoms of a Delatestryl Pulmonary Embolism may include chest pain, trouble breathing, cyanosis (bluish color of the skin & lips), and leg swelling.
Free Delatestryl Pulmonary Embolism Lawsuit Evaluation: If you or a loved one suffered a pulmonary embolism after using Delatestryl, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of Delatestryl and we can help.
What is Delatestryl?
Delatestryl is an FDA-approved androgen (male hormone) drug prescribed to replace testosterone in men who have clinically diagnosed low or non-existent natural testosterone levels. This medication is designed to work by replacing the testosterone that the user’s body is lacking. Delatestryl should only be prescribed if testosterone deficiency has been conclusively diagnosed by a doctor or other medical professional.
Delatestryl & Pulmonary Embolism
A recent study published in the medical journal PLOS ONE determined that Delatestryl and other similar testosterone boosters may double the risk of heart attack in men aged 65 or older, and triple the risk for younger men with a history of heart problems. Another study published in the Journal of the American Medical Association (JAMA) found a nearly 30% increased risk of heart attack in the first three months of beginning treatment with a testosterone supplement like Delatestryl. Taking these findings into consideration, it appears likely that the risks associated with using Delatestryl may far outweigh any potential benefit.
A groundbreaking study into the risk of pulmonary embolism posed by testosterone therapy products was published in the October 2011 edition of Translational Research. A research team led by cardiologist Dr. Charles Glueck identified multiple cases of pulmonary embolism in men undergoing testosterone supplementation, most often the result of previously-undiagnosed risk-factors for blood clots, estimated to affect approximately 5% of men.
What is a Pulmonary Embolism?
A pulmonary embolism occurs when an artery to the lungs becomes obstructed, resulting in the body being deprived of oxygenated (red) blood. If untreated, this can lead to brain damage or even death in a short amount of time. Pulmonary embolisms are typically caused by deep vein thrombosis, a condition that occurs when a blood clot in the leg breaks free, migrates through the blood, and becomes trapped in the lungs.
Signs and symptoms of a Delatestryl pulmonary embolism may include:
- Chest Pain
- Coughing up blood
- Shortness of breath
- Leg pain and welling
- Bluish skin coloration (cyanosis)
- Irregular heartbeat
Delatestryl Side Effects
In addition to having the potential to cause pulmonary embolism, Delatestryl has been linked to the following serious side effects:
Other, less severe Delatestryl side effects may include:
- Hair loss
- Trouble sleeping
- Change in sexual desire
- Redness/swelling of the skin
- Change in skin color
Do I Have a Delatestryl Pulmonary Embolism Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Delatestryl Lawsuits. We are handling individual litigation nationwide and currently accepting new Delatestryl pulmonary embolism cases in all 50 states.
Free Delatestryl Pulmonary Embolism Lawsuit Evaluation: If you or a loved one suffered a pulmonary embolism after taking Delatestryl, you should contact our law firm immediately. You may be entitled to compensation by filing a Delatestryl Pulmonary Embolism Suit and we can help.